Invention Grant
- Patent Title: Neurotrophic factor MANF and uses thereof
- Patent Title (中): 神经营养因子MANF及其用途
-
Application No.: US12433345Application Date: 2009-04-30
-
Publication No.: US08853166B2Publication Date: 2014-10-07
- Inventor: Mart Saarma , Päivi Lindholm , Merja Voutilainen , Johan Peränen , Raimo Tuominen , Mikko Airavaara , Veli-Matti Leppänen , Maria Lindahl , Jaan-Olle Andressoo
- Applicant: Mart Saarma , Päivi Lindholm , Merja Voutilainen , Johan Peränen , Raimo Tuominen , Mikko Airavaara , Veli-Matti Leppänen , Maria Lindahl , Jaan-Olle Andressoo
- Applicant Address: FI Helsinki
- Assignee: Herantis Pharma PLC.
- Current Assignee: Herantis Pharma PLC.
- Current Assignee Address: FI Helsinki
- Agency: Birch, Stewart, Kolasch & Birch, LLP.
- Main IPC: A61P25/16
- IPC: A61P25/16 ; C07K14/475 ; A61K38/18 ; C12Q1/68 ; C12N15/12
Abstract:
The present invention generally relates to the field of treatment of neuronal disorders and more particularly to neurotrophic factor MANF and uses thereof. The present invention provides a pharmaceutical compound comprising MANF nucleic acid molecule, MANF protein or a functional fragment thereof for the treatment of a peripherial neuropathy including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction and ischemic brain injury.
Public/Granted literature
- US20090282495A1 NEUROTROPHIC FACTOR MANF AND USES THEREOF Public/Granted day:2009-11-12
Information query
